These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 30420907)
1. Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease. Sivanesan S; Mundugaru R; Rajadas J Oxid Med Cell Longev; 2018; 2018():2764831. PubMed ID: 30420907 [TBL] [Abstract][Full Text] [Related]
2. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease. Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites. Bretou M; Sannerud R; Escamilla-Ayala A; Leroy T; Vrancx C; Van Acker ZP; Perdok A; Vermeire W; Vorsters I; Van Keymolen S; Maxson M; Pavie B; Wierda K; Eskelinen EL; Annaert W Dev Cell; 2024 Jun; 59(12):1571-1592.e9. PubMed ID: 38626765 [TBL] [Abstract][Full Text] [Related]
5. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251 [TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. Nixon RA FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518 [TBL] [Abstract][Full Text] [Related]
7. Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease? Lauritzen I; Pardossi-Piquard R; Bourgeois A; Bécot A; Checler F Curr Alzheimer Res; 2019; 16(5):453-457. PubMed ID: 30907322 [TBL] [Abstract][Full Text] [Related]
8. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. Boland B; Smith DA; Mooney D; Jung SS; Walsh DM; Platt FM J Biol Chem; 2010 Nov; 285(48):37415-26. PubMed ID: 20864542 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912 [TBL] [Abstract][Full Text] [Related]
10. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance. Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556 [TBL] [Abstract][Full Text] [Related]
11. NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models. Yang C; Cai CZ; Song JX; Tan JQ; Durairajan SSK; Iyaswamy A; Wu MY; Chen LL; Yue Z; Li M; Lu JH Autophagy; 2017; 13(12):2028-2040. PubMed ID: 28980867 [TBL] [Abstract][Full Text] [Related]
12. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. Sergeant N; David JP; Champain D; Ghestem A; Wattez A; Delacourte A J Neurochem; 2002 May; 81(4):663-72. PubMed ID: 12065626 [TBL] [Abstract][Full Text] [Related]
13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
14. A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome. Hein LK; Apaja PM; Hattersley K; Grose RH; Xie J; Proud CG; Sargeant TJ Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1554-1565. PubMed ID: 28641977 [TBL] [Abstract][Full Text] [Related]